Categories: Health

BioCorRx Partners with Government Plus to Expand its Beat

Published by
Globe News Wire


ANAHEIM, CA, Dec. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire  BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that it has partnered with Government Plus LLC, a leading provider of private sector healthcare to veterans, to nationally expand its Beat Addiction Recovery Program.

Ed LeTourneau, CEO of Government Plus, stated, “At Government Plus, our mission is to bring new innovations to the market with a focus on eliminating addictions and other life controlling mental health issues while serving our nation’s veterans and active-duty service members. After many months of exploration, we are proud to announce that we have selected BioCorRx as our exclusive addiction treatment partner for our veteran clients. After many years of studying the treatment options routinely utilized in the substance abuse industry and the poor track record with negative outcomes, Government Plus sought better treatment methods that use a more modern approach.  BioCorRx has demonstrated to us that they’re a leader in groundbreaking advancements in the effective use of naltrexone and the Beat Addiction Recovery Program.  We are excited about joining forces and being able to offer the effective Beat Addiction Recovery Program with game changing positive outcomes that will keep us on our growth trajectory for years to come. We believe our partnership will truly save lives for generations.” 

Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., commented, “We are very excited to partner with Government Plus. The entrepreneurs that founded Government Plus have strong backgrounds in business operations as well as solid relationships and experience in government contracting. We are aligned with their goal of providing the best possible treatment solutions for veterans and we look forward to expanding our Beat Addiction Recovery Program nationally.”

About BioCorRx
BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Beat Addiction Recovery is a substance use disorder recovery program that typically includes BioCorRx’s proprietary Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx® Weight Loss Program is also a medication assisted weight loss program that includes access to concierge on-demand wellness specialists: nutritionists, fitness experts and personal support from behavioral experts; please visit www.uncraverx.com for more information on UnCraveRx®. The Company also controls BioCorRx Pharmaceuticals, a clinical stage drug development subsidiary currently seeking FDA approval for BICX104, an implantable naltrexone pellet for treatment of alcohol and opioid use disorders. For more information on BICX and its subsidiary pipeline, please visit www.BioCorRx.com.

Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown. risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

BioCorRx Inc.
investors@BioCorRx.com
714-462-4880

Investor Relations:
Crescendo Communications, LLC
212- 671-1020 x304
bicx@crescendo-ir.com

Media Contact
PhillComm Global
BioCorRx@PhillComm.Global
704-942-1557

Globe News Wire
Share
Published by
Globe News Wire

Recent Posts

Metro Supply Chain partners with the Arrows to support

TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Metro Supply Chain Inc., a leading provider of… Read More

36 mins ago

Innofactor Plc: Share Repurchase 27.1.2023

January 27, 2023 11:30 ET | Source: Innofactor Plc Innofactor Plc Espoo, FINLAND English Finnish… Read More

49 mins ago

Extraordinary General Meeting of February 15, 2023: Notice

Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents Paris,… Read More

51 mins ago

DAS Technology Unveils Groundbreaking CX Automotive Mystery Shop Study at NADA 2023

Leading Customer Data and Experience Platform (CDXP) technology company unveils insights from 1,850 auto dealership… Read More

52 mins ago

Visteon to Announce Fourth Quarter and Full-Year 2022

VAN BUREN TOWNSHIP, Mich., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a… Read More

2 hours ago

Savista Receives HFMA Peer Review Designation

CHICAGO, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed… Read More

2 hours ago